Medco Health Solutions hopes that what's good for diabetes patients is also good for its bottom line [1]. The company has agreed to pay $1.5 billion to acquire PolyMedica, the nation's largest supplier of blood-glucose testing supplies and other diabetes-related services.

The two companies already have been working together; Medco fills some 50,000 scrips a week for PolyMedica patients, and Polymedica has offered testing supplies and Medicare Part B management services to some Medco clients. The companies say the deal creates "the nation's most advanced large-scale practice focused on diabetes care."

Medco will pay $53 per share for PolyMedica, which closed Monday at $45.29. Together, the two companies will serve some 3.8 million diabetes patients.

- read the CNN report [2] on the deal

Related Articles:
Diabetes epidemic triggers soaring drug market. Report [3]
Medco reaches settlement with DOJ. Report [4]
Medco to launch e-prescribing study with CMS. Report [5]